New drug aims to restart periods in women with exercise-related amenorrhea

NCT ID NCT07235917

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study tests an experimental drug called mibavademab in 34 women with Functional Hypothalamic Amenorrhea (FHA), a condition where periods stop due to stress or intense exercise. The goal is to see if the drug can help the body produce the hormones needed for ovulation and improve bone health. Participants will receive either the drug or a placebo, and researchers will monitor hormone levels and side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL HYPOTHALAMIC AMENORRHEA (FHA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arensia Exploratory Medicine Clinic

    RECRUITING

    Phoenix, Arizona, 85015, United States

  • Focus Clinical Research

    RECRUITING

    West Hills, California, 91307, United States

  • Mayo Clinic Florida

    RECRUITING

    Jacksonville, Florida, 32224, United States

  • OBGYN Associates of Erie

    RECRUITING

    Erie, Pennsylvania, 16507, United States

  • Oregon Health and Science University (OHSU)

    RECRUITING

    Portland, Oregon, 97239, United States

  • Penn State Health Milton South Hershey Medical Center

    RECRUITING

    Hershey, Pennsylvania, 17033, United States

  • Tidewater Clinical Research - Tidewater Physicians for Women

    RECRUITING

    Norfolk, Virginia, 23502, United States

  • University of Virginia School of Medicine

    RECRUITING

    Charlottesville, Virginia, 22908, United States

  • Yale University School of Medicine

    RECRUITING

    New Haven, Connecticut, 06510, United States

  • Zillan Clinical Research

    RECRUITING

    Houston, Texas, 77082, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.